{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:17:24Z","timestamp":1788135444208,"version":"build-2803163510"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA285774-01"],"award-info":[{"award-number":["1R01CA285774-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76143-w","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:17:17Z","timestamp":1785428237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia-induced metastatic heterogeneity in pancreatic cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Pradeep Moon","family":"Gunasekaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3875-0257","authenticated-orcid":false,"given":"Polina","family":"Guseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9384-6387","authenticated-orcid":false,"given":"Yoke-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajika","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8384-9674","authenticated-orcid":false,"given":"Alexander","family":"Kley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Ghosh Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Masoudpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Watkins","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyann","family":"Franciosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafiq","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Zachariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0942-7282","authenticated-orcid":false,"given":"Julie Zhouli","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Guoping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9754-7712","authenticated-orcid":false,"given":"Shin-Heng","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"76143_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle, H. et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297, 267\u2013277 (2007).","journal-title":"JAMA"},{"key":"76143_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186, 1564\u20131579 (2023).","journal-title":"Cell"},{"key":"76143_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ccell.2019.12.004","volume":"37","author":"NJ Birkbak","year":"2020","unstructured":"Birkbak, N. J. & McGranahan, N. Cancer genome evolutionary trajectories in metastasis. Cancer Cell 37, 8\u201319 (2020).","journal-title":"Cancer Cell"},{"key":"76143_CR4","doi-asserted-by":"crossref","unstructured":"Connor, A. A. et al. Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases. Cancer Cell 35, 267\u2013282.e267 (2019).","DOI":"10.1016\/j.ccell.2018.12.010"},{"key":"76143_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ng.3764","volume":"49","author":"AP Makohon-Moore","year":"2017","unstructured":"Makohon-Moore, A. P. et al. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Nat. Genet 49, 358\u2013366 (2017).","journal-title":"Nat. Genet"},{"key":"76143_CR6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ccell.2021.05.005","volume":"39","author":"KP Simeonov","year":"2021","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell 39, 1150\u20131162.e1159 (2021).","journal-title":"Cancer Cell"},{"key":"76143_CR7","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S. et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 184, 6119\u20136137 e6126 (2021).","journal-title":"Cell"},{"key":"76143_CR8","doi-asserted-by":"publisher","unstructured":"Adams, C. R. et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. Elife 8 https:\/\/doi.org\/10.7554\/eLife.45313 (2019).","DOI":"10.7554\/eLife.45313"},{"key":"76143_CR9","doi-asserted-by":"publisher","first-page":"E12343","DOI":"10.1073\/pnas.1812915116","volume":"115","author":"FH Hamdan","year":"2018","unstructured":"Hamdan, F. H. & Johnsen, S. A. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network. Proc. Natl. Acad. Sci. USA 115, E12343\u2013E12352 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR10","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.celrep.2018.10.051","volume":"25","author":"TDD Somerville","year":"2018","unstructured":"Somerville, T. D. D. et al. TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma. Cell Rep. 25, 1741\u20131755.e1747 (2018).","journal-title":"Cell Rep."},{"key":"76143_CR11","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1158\/2159-8290.CD-17-0250","volume":"7","author":"SH Chiou","year":"2017","unstructured":"Chiou, S. H. et al. BLIMP1 induces transient metastatic heterogeneity in pancreatic cancer. Cancer Discov. 7, 1184\u20131199 (2017).","journal-title":"Cancer Discov."},{"key":"76143_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"AM Krebs","year":"2017","unstructured":"Krebs, A. M. et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat. Cell Biol. 19, 518\u2013529 (2017).","journal-title":"Nat. Cell Biol."},{"key":"76143_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cell.2017.07.007","volume":"170","author":"JS Roe","year":"2017","unstructured":"Roe, J. S. et al. Enhancer reprogramming promotes pancreatic cancer metastasis. Cell 170, 875\u2013888.e820 (2017).","journal-title":"Cell"},{"key":"76143_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102161","volume":"38","author":"M Milan","year":"2019","unstructured":"Milan, M. et al. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. EMBO J. 38, e102161 (2019).","journal-title":"EMBO J."},{"key":"76143_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1101\/gad.263327.115","volume":"30","author":"S Takano","year":"2016","unstructured":"Takano, S. et al. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes Dev. 30, 233\u2013247 (2016).","journal-title":"Genes Dev."},{"key":"76143_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109443","volume":"36","author":"C Dai","year":"2021","unstructured":"Dai, C. et al. SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization. Cell Rep. 36, 109443 (2021).","journal-title":"Cell Rep."},{"key":"76143_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald, O. G. et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat. Genet 49, 367\u2013376 (2017).","journal-title":"Nat. Genet"},{"key":"76143_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin, E. B. & Giaccia, A. J. Hypoxic control of metastasis. Science 352, 175\u2013180 (2016).","journal-title":"Science"},{"key":"76143_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"76143_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349\u2013361 (2012).","journal-title":"Cell"},{"key":"76143_CR21","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/s41586-025-08671-2","volume":"640","author":"L Perelli","year":"2025","unstructured":"Perelli, L. et al. Evolutionary fingerprints of epithelial-to-mesenchymal transition. Nature 640, 1083\u20131092 (2025).","journal-title":"Nature"},{"key":"76143_CR22","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1053\/j.gastro.2020.07.046","volume":"159","author":"A Tiwari","year":"2020","unstructured":"Tiwari, A. et al. Loss of HIF1A from pancreatic cancer cells increases expression of PPP1R1B and degradation of p53 to promote invasion and metastasis. Gastroenterology 159, 1882\u20131897 e1885 (2020).","journal-title":"Gastroenterology"},{"key":"76143_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/2159-8290.CD-15-0822","volume":"6","author":"KE Lee","year":"2016","unstructured":"Lee, K. E. et al. Hif1a deletion reveals pro-neoplastic function of B cells in pancreatic neoplasia. Cancer Discov. 6, 256\u2013269 (2016).","journal-title":"Cancer Discov."},{"key":"76143_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2217\/epi.15.24","volume":"7","author":"RL Hancock","year":"2015","unstructured":"Hancock, R. L., Dunne, K., Walport, L. J., Flashman, E. & Kawamura, A. Epigenetic regulation by histone demethylases in hypoxia. Epigenomics 7, 791\u2013811 (2015).","journal-title":"Epigenomics"},{"key":"76143_CR25","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/BJ20140754","volume":"462","author":"A Shmakova","year":"2014","unstructured":"Shmakova, A., Batie, M., Druker, J. & Rocha, S. Chromatin and oxygen sensing in the context of JmjC histone demethylases. Biochem J. 462, 385\u2013395 (2014).","journal-title":"Biochem J."},{"key":"76143_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich, J. et al. Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell 33, 512\u2013526 e518 (2018).","journal-title":"Cancer Cell"},{"key":"76143_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"76143_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley, K. A. et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158, 929\u2013944 (2014).","journal-title":"Cell"},{"key":"76143_CR29","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.85.24.9533","volume":"85","author":"SD Young","year":"1988","unstructured":"Young, S. D., Marshall, R. S. & Hill, R. P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85, 9533\u20139537 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00781-9","author":"A Suvac","year":"2025","unstructured":"Suvac, A., Ashton, J. & Bristow, R. G. Tumour hypoxia in driving genomic instability and tumour evolution. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-024-00781-9 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"76143_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14052-x","volume":"11","author":"V Bhandari","year":"2020","unstructured":"Bhandari, V., Li, C. H., Bristow, R. G., Boutros, P. C. & Consortium, P. Divergent mutational processes distinguish hypoxic and normoxic tumours. Nat. Commun. 11, 737 (2020).","journal-title":"Nat. Commun."},{"key":"76143_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele, C. D. et al. Signatures of copy number alterations in human cancer. Nature 606, 984\u2013991 (2022).","journal-title":"Nature"},{"key":"76143_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1097-2765(00)80137-9","volume":"2","author":"A Coquelle","year":"1998","unstructured":"Coquelle, A., Toledo, F., Stern, S., Bieth, A. & Debatisse, M. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2, 259\u2013265 (1998).","journal-title":"Mol. Cell"},{"key":"76143_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/jnci\/82.8.684","volume":"82","author":"CK Luk","year":"1990","unstructured":"Luk, C. K., Veinot-Drebot, L., Tjan, E. & Tannock, I. F. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines. J. Natl. Cancer Inst. 82, 684\u2013692 (1990).","journal-title":"J. Natl. Cancer Inst."},{"key":"76143_CR35","first-page":"509","volume":"33","author":"U Fischer","year":"2008","unstructured":"Fischer, U., Radermacher, J., Mayer, J., Mehraein, Y. & Meese, E. Tumor hypoxia: Impact on gene amplification in glioblastoma. Int J. Oncol. 33, 509\u2013515 (2008).","journal-title":"Int J. Oncol."},{"key":"76143_CR36","doi-asserted-by":"publisher","first-page":"5978","DOI":"10.1073\/pnas.83.16.5978","volume":"83","author":"GC Rice","year":"1986","unstructured":"Rice, G. C., Hoy, C. & Schimke, R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 83, 5978\u20135982 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR37","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1101\/gad.259796.115","volume":"29","author":"JC Black","year":"2015","unstructured":"Black, J. C. et al. Hypoxia drives transient site-specific copy gain and drug-resistant gene expression. Genes Dev. 29, 1018\u20131031 (2015).","journal-title":"Genes Dev."},{"key":"76143_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet 52, 231\u2013240 (2020).","journal-title":"Nat. Genet"},{"key":"76143_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature25459","volume":"554","author":"S Mueller","year":"2018","unstructured":"Mueller, S. et al. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature 554, 62\u201368 (2018).","journal-title":"Nature"},{"key":"76143_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/gcc.10063","volume":"34","author":"M Heidenblad","year":"2002","unstructured":"Heidenblad, M. et al. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer 34, 211\u2013223 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"76143_CR41","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","volume":"149","author":"H Ying","year":"2012","unstructured":"Ying, H. et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656\u2013670 (2012).","journal-title":"Cell"},{"key":"76143_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41586-019-1832-9","volume":"576","author":"CR Amendola","year":"2019","unstructured":"Amendola, C. R. et al. KRAS4A directly regulates hexokinase 1. Nature 576, 482\u2013486 (2019).","journal-title":"Nature"},{"key":"76143_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature12040","volume":"496","author":"J Son","year":"2013","unstructured":"Son, J. et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101\u2013105 (2013).","journal-title":"Nature"},{"key":"76143_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","volume":"2","author":"S Mukhopadhyay","year":"2021","unstructured":"Mukhopadhyay, S., Vander Heiden, M. G. & McCormick, F. The Metabolic Landscape of RAS-Driven Cancers from biology to therapy. Nat. Cancer 2, 271\u2013283 (2021).","journal-title":"Nat. Cancer"},{"key":"76143_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","volume":"13","author":"SB Kemp","year":"2023","unstructured":"Kemp, S. B. et al. Efficacy of a small-molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer. Cancer Discov. 13, 298\u2013311 (2023).","journal-title":"Cancer Discov."},{"key":"76143_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21736-w","volume":"12","author":"I Ischenko","year":"2021","unstructured":"Ischenko, I. et al. KRAS drives immune evasion in a genetic model of pancreatic cancer. Nat. Commun. 12, 1482 (2021).","journal-title":"Nat. Commun."},{"key":"76143_CR47","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836\u2013847 (2012).","journal-title":"Cancer Cell"},{"key":"76143_CR48","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/2159-8290.CD-20-0133","volume":"10","author":"K Miyabayashi","year":"2020","unstructured":"Miyabayashi, K. et al. Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes. Cancer Discov. 10, 1566\u20131589 (2020).","journal-title":"Cancer Discov."},{"key":"76143_CR49","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1073\/pnas.1000401107","volume":"107","author":"DA Hsia","year":"2010","unstructured":"Hsia, D. A. et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc. Natl. Acad. Sci. USA 107, 9671\u20139676 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1242\/dev.074138","volume":"139","author":"A Ishimura","year":"2012","unstructured":"Ishimura, A. et al. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development 139, 749\u2013759 (2012).","journal-title":"Development"},{"key":"76143_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110050","volume":"37","author":"N Zaghet","year":"2021","unstructured":"Zaghet, N. et al. Coordinated maintenance of H3K36\/K27 methylation by histone demethylases preserves germ cell identity and immortality. Cell Rep. 37, 110050 (2021).","journal-title":"Cell Rep."},{"key":"76143_CR52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbrc.2012.02.115","volume":"420","author":"S Oh","year":"2012","unstructured":"Oh, S. & Janknecht, R. Histone demethylase JMJD5 is essential for embryonic development. Biochem Biophys. Res. Commun. 420, 61\u201365 (2012).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"76143_CR53","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/stem.1724","volume":"32","author":"H Zhu","year":"2014","unstructured":"Zhu, H., Hu, S. & Baker, J. JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells. Stem Cells 32, 2098\u20132110 (2014).","journal-title":"Stem Cells"},{"key":"76143_CR54","doi-asserted-by":"publisher","unstructured":"Fletcher, S. C. et al. Impaired protein hydroxylase activity causes replication stress and developmental abnormalities in humans. J. Clin. Invest 133 https:\/\/doi.org\/10.1172\/JCI152784 (2023).","DOI":"10.1172\/JCI152784"},{"key":"76143_CR55","doi-asserted-by":"publisher","first-page":"e1006632","DOI":"10.1371\/journal.pgen.1006632","volume":"13","author":"PG Amendola","year":"2017","unstructured":"Amendola, P. G. et al. JMJD-5\/KDM8 regulates H3K36me2 and is required for late steps of homologous recombination and genome integrity. PLoS Genet 13, e1006632 (2017).","journal-title":"PLoS Genet"},{"key":"76143_CR56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.celrep.2014.05.050","volume":"8","author":"E Marcon","year":"2014","unstructured":"Marcon, E. et al. Human-chromatin-related protein interactions identify a demethylase complex required for chromosome segregation. Cell Rep. 8, 297\u2013310 (2014).","journal-title":"Cell Rep."},{"key":"76143_CR57","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1101\/gad.264861.115","volume":"29","author":"SH Chiou","year":"2015","unstructured":"Chiou, S. H. et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR\/Cas9-mediated somatic genome editing. Genes Dev. 29, 1576\u20131585 (2015).","journal-title":"Genes Dev."},{"key":"76143_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01519-y","volume":"8","author":"IP Winters","year":"2017","unstructured":"Winters, I. P. et al. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nat. Commun. 8, 2053 (2017).","journal-title":"Nat. Commun."},{"key":"76143_CR59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1073\/pnas.0908428107","volume":"107","author":"JP Morton","year":"2010","unstructured":"Morton, J. P. et al. Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer. Proc. Natl. Acad. Sci. USA 107, 246\u2013251 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR60","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2014.01.066","volume":"157","author":"S Weissmueller","year":"2014","unstructured":"Weissmueller, S. et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor beta signaling. Cell 157, 382\u2013394 (2014).","journal-title":"Cell"},{"key":"76143_CR61","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ccell.2024.02.017","volume":"42","author":"P Di Chiaro","year":"2024","unstructured":"Di Chiaro, P. et al. Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer. Cancer Cell 42, 662\u2013681 e610 (2024).","journal-title":"Cancer Cell"},{"key":"76143_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A. et al. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat. Cancer 1, 59\u201374 (2020).","journal-title":"Nat. Cancer"},{"key":"76143_CR63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell, L. et al. Cholesterol pathway inhibition induces TGF-beta signaling to promote basal differentiation in pancreatic cancer. Cancer Cell 38, 567\u2013583.e511 (2020).","journal-title":"Cancer Cell"},{"key":"76143_CR64","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.cell.2013.05.038","volume":"153","author":"A Kumagai","year":"2013","unstructured":"Kumagai, A. et al. A bilirubin-inducible fluorescent protein from eel muscle. Cell 153, 1602\u20131611 (2013).","journal-title":"Cell"},{"key":"76143_CR65","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1126\/science.aaw1026","volume":"363","author":"AA Chakraborty","year":"2019","unstructured":"Chakraborty, A. A. et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science 363, 1217\u20131222 (2019).","journal-title":"Science"},{"key":"76143_CR66","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1021\/bi3012466","volume":"51","author":"B Cascella","year":"2012","unstructured":"Cascella, B. & Mirica, L. M. Kinetic analysis of iron-dependent histone demethylases: alpha-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells. Biochemistry 51, 8699\u20138701 (2012).","journal-title":"Biochemistry"},{"key":"76143_CR67","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1021\/acschembio.6b00958","volume":"12","author":"RL Hancock","year":"2017","unstructured":"Hancock, R. L., Masson, N., Dunne, K., Flashman, E. & Kawamura, A. The activity of JmjC histone lysine demethylase KDM4A is highly sensitive to oxygen concentrations. ACS Chem. Biol. 12, 1011\u20131019 (2017).","journal-title":"ACS Chem. Biol."},{"key":"76143_CR68","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1107\/S0907444913016600","volume":"69","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. Structure of the JmjC-domain-containing protein JMJD5. Acta Crystallogr. D Biol. Crystallogr. 69, 1911\u20131920 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"76143_CR69","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/MCB.00513-12","volume":"32","author":"PA Del Rizzo","year":"2012","unstructured":"Del Rizzo, P. A., Krishnan, S. & Trievel, R. C. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Mol. Cell Biol. 32, 4044\u20134052 (2012).","journal-title":"Mol. Cell Biol."},{"key":"76143_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans, S. J. & Taylor, C. T. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J. Physiol. 599, 23\u201337 (2021).","journal-title":"J. Physiol."},{"key":"76143_CR71","unstructured":"Cancer Genome Atlas Research Network Electronic address, a. a. d. h. e. & Cancer Genome Atlas Research, N. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell 32, 185\u2013203.e113 (2017)."},{"key":"76143_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23237-2","volume":"12","author":"S Dhara","year":"2021","unstructured":"Dhara, S. et al. Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility. Nat. Commun. 12, 3044 (2021).","journal-title":"Nat. Commun."},{"key":"76143_CR73","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"C International Cancer Genome","year":"2010","unstructured":"International Cancer Genome, C. et al. International network of cancer genome projects. Nature 464, 993\u2013998 (2010).","journal-title":"Nature"},{"key":"76143_CR74","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang, W. L. et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat. Genet 54, 1178\u20131191 (2022).","journal-title":"Nat. Genet"},{"key":"76143_CR75","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet"},{"key":"76143_CR76","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med"},{"key":"76143_CR77","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","volume":"24","author":"KL Aung","year":"2018","unstructured":"Aung, K. L. et al. Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial. Clin. Cancer Res. 24, 1344\u20131354 (2018).","journal-title":"Clin. Cancer Res."},{"key":"76143_CR78","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","volume":"26","author":"GM O\u2019Kane","year":"2020","unstructured":"O\u2019Kane, G. M. et al. GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer. Clin. Cancer Res. 26, 4901\u20134910 (2020).","journal-title":"Clin. Cancer Res."},{"key":"76143_CR79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914915116","author":"RL Porter","year":"2019","unstructured":"Porter, R. L. et al. Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1914915116 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR80","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","volume":"155","author":"F Puleo","year":"2018","unstructured":"Puleo, F. et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology 155, 1999\u20132013.e1993 (2018).","journal-title":"Gastroenterology"},{"key":"76143_CR81","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"76143_CR82","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."},{"key":"76143_CR83","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41588-019-0489-5","volume":"51","author":"JL McFaline-Figueroa","year":"2019","unstructured":"McFaline-Figueroa, J. L. et al. A pooled single-cell genetic screen identifies regulatory checkpoints in the continuum of the epithelial-to-mesenchymal transition. Nat. Genet 51, 1389\u20131398 (2019).","journal-title":"Nat. Genet"},{"key":"76143_CR84","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/modpathol.2013.71","volume":"26","author":"AM Krasinskas","year":"2013","unstructured":"Krasinskas, A. M., Moser, A. J., Saka, B., Adsay, N. V. & Chiosea, S. I. KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas. Mod. Pathol. 26, 1346\u20131354 (2013).","journal-title":"Mod. Pathol."},{"key":"76143_CR85","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1158\/2159-8290.CD-19-1299","volume":"10","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discov. 10, 854\u2013871 (2020).","journal-title":"Cancer Discov."},{"key":"76143_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18638-8","volume":"11","author":"J Xin","year":"2020","unstructured":"Xin, J. et al. Chromatin accessibility landscape and regulatory network of high-altitude hypoxia adaptation. Nat. Commun. 11, 4928 (2020).","journal-title":"Nat. Commun."},{"key":"76143_CR87","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.tem.2017.07.003","volume":"28","author":"IMN Wortel","year":"2017","unstructured":"Wortel, I. M. N., van der Meer, L. T., Kilberg, M. S. & van Leeuwen, F. N. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol. Metab. 28, 794\u2013806 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"76143_CR88","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2016.06.056","volume":"166","author":"IIC Chio","year":"2016","unstructured":"Chio, I. I. C. et al. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166, 963\u2013976 (2016).","journal-title":"Cell"},{"key":"76143_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature07056","volume":"454","author":"TS Mikkelsen","year":"2008","unstructured":"Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49\u201355 (2008).","journal-title":"Nature"},{"key":"76143_CR90","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 (2018).","journal-title":"Nature"},{"key":"76143_CR91","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1074\/jbc.M115.672642","volume":"291","author":"Z He","year":"2016","unstructured":"He, Z. et al. JMJD5 (Jumonji Domain-containing 5) associates with spindle microtubules and is required for proper mitosis. J. Biol. Chem. 291, 4684\u20134697 (2016).","journal-title":"J. Biol. Chem."},{"key":"76143_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1747-1028-7-19","volume":"7","author":"WT Silkworth","year":"2012","unstructured":"Silkworth, W. T. & Cimini, D. Transient defects of mitotic spindle geometry and chromosome segregation errors. Cell Div. 7, 19 (2012).","journal-title":"Cell Div."},{"key":"76143_CR93","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"76143_CR94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr, E. M., Gaude, E., Turrell, F. K., Frezza, C. & Martins, C. P. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature 531, 110\u2013113 (2016).","journal-title":"Nature"},{"key":"76143_CR95","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson, D. R. et al. Integrative clinical genomics of metastatic cancer. Nature 548, 297\u2013303 (2017).","journal-title":"Nature"},{"key":"76143_CR96","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0092-8674(00)80862-4","volume":"101","author":"J Grosshans","year":"2000","unstructured":"Grosshans, J. & Wieschaus, E. A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila. Cell 101, 523\u2013531 (2000).","journal-title":"Cell"},{"key":"76143_CR97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1242\/dev.00971","volume":"131","author":"MS Murakami","year":"2004","unstructured":"Murakami, M. S., Moody, S. A., Daar, I. O. & Morrison, D. K. Morphogenesis during Xenopus gastrulation requires Wee1-mediated inhibition of cell proliferation. Development 131, 571\u2013580 (2004).","journal-title":"Development"},{"key":"76143_CR98","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/onc.2015.216","volume":"35","author":"E Hessmann","year":"2016","unstructured":"Hessmann, E., Schneider, G., Ellenrieder, V. & Siveke, J. T. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies. Oncogene 35, 1609\u20131618 (2016).","journal-title":"Oncogene"},{"key":"76143_CR99","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1158\/2159-8290.CD-20-1826","volume":"12","author":"R Maddipati","year":"2022","unstructured":"Maddipati, R. et al. MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma. Cancer Discov. 12, 542\u2013561 (2022).","journal-title":"Cancer Discov."},{"key":"76143_CR100","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41416-019-0507-5","volume":"121","author":"G Brar","year":"2019","unstructured":"Brar, G. et al. Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. Br. J. Cancer 121, 264\u2013270 (2019).","journal-title":"Br. J. Cancer"},{"key":"76143_CR101","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/j.celrep.2016.11.022","volume":"17","author":"V Comaills","year":"2016","unstructured":"Comaills, V. et al. Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition. Cell Rep. 17, 2632\u20132647 (2016).","journal-title":"Cell Rep."},{"key":"76143_CR102","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1073\/pnas.96.7.3940","volume":"96","author":"DW Felsher","year":"1999","unstructured":"Felsher, D. W. & Bishop, J. M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl. Acad. Sci. USA 96, 3940\u20133944 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76143_CR103","doi-asserted-by":"publisher","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","volume":"4","author":"A Kuzyk","year":"2014","unstructured":"Kuzyk, A. & Mai, S. c-MYC-induced genomic instability. Cold Spring Harb. Perspect. Med. 4, a014373 (2014).","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"76143_CR104","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/PPO.0b013e31827ab4c4","volume":"18","author":"CB Westphalen","year":"2012","unstructured":"Westphalen, C. B. & Olive, K. P. Genetically engineered mouse models of pancreatic cancer. Cancer J. 18, 502\u2013510 (2012).","journal-title":"Cancer J."},{"key":"76143_CR105","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1158\/2159-8290.CD-19-0463","volume":"10","author":"TL Clarke","year":"2020","unstructured":"Clarke, T. L. et al. Histone lysine methylation dynamics control EGFR DNA copy-number amplification. Cancer Discov. 10, 306\u2013325 (2020).","journal-title":"Cancer Discov."},{"key":"76143_CR106","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cell.2013.06.051","volume":"154","author":"JC Black","year":"2013","unstructured":"Black, J. C. et al. KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumors. Cell 154, 541\u2013555 (2013).","journal-title":"Cell"},{"key":"76143_CR107","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10371","volume":"477","author":"Q Zhu","year":"2011","unstructured":"Zhu, Q. et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 477, 179\u2013184 (2011).","journal-title":"Nature"},{"key":"76143_CR108","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.cell.2016.07.005","volume":"166","author":"IY Park","year":"2016","unstructured":"Park, I. Y. et al. Dual chromatin and cytoskeletal remodeling by SETD2. Cell 166, 950\u2013962 (2016).","journal-title":"Cell"},{"key":"76143_CR109","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","volume":"37","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. The International Cancer Genome Consortium Data Portal. Nat. Biotechnol. 37, 367\u2013369 (2019).","journal-title":"Nat. Biotechnol."},{"key":"76143_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-1157","volume":"15","author":"JZ Ni","year":"2014","unstructured":"Ni, J. Z., Chen, E. & Gu, S. G. Complex coding of endogenous siRNA, transcriptional silencing and H3K9 methylation on native targets of germline nuclear RNAi in C. elegans. BMC Genomics 15, 1157 (2014).","journal-title":"BMC Genomics"},{"key":"76143_CR111","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"},{"key":"76143_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"76143_CR113","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"76143_CR114","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/nmeth.2688","volume":"10","author":"JD Buenrostro","year":"2013","unstructured":"Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213\u20131218 (2013).","journal-title":"Nat. Methods"},{"key":"76143_CR115","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nprot.2012.039","volume":"7","author":"T Baslan","year":"2012","unstructured":"Baslan, T. et al. Genome-wide copy number analysis of single cells. Nat. Protoc. 7, 1024\u20131041 (2012).","journal-title":"Nat. Protoc."},{"key":"76143_CR116","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-0329-0_14","volume":"1136","author":"F Faggioli","year":"2014","unstructured":"Faggioli, F., Vijg, J. & Montagna, C. Four-color FISH for the detection of low-level aneuploidy in interphase cells. Methods Mol. Biol. 1136, 291\u2013305 (2014).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76143-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76143-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76143-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:02:30Z","timestamp":1788134550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76143-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76143"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76143-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.M. is a co-founder of OncuraDX and Salium. None of these companies are currently providing support for the Montagna laboratory. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9256"}}